Coumarin compounds against Alzheimer's disease: An in-silico approach
Alzheimer's disease, one of the most common causes of senile dementia, has no cure which makes the development of new treatments crucial. In this regard, secondary metabolites from plants have shown important bioactivity, including the inhibitory effect against acetylcholinesterase enzyme (AChE...
Saved in:
| Main Authors: | Mayra Avelar, Patricia Fernanda Delgado-Acosta, Ricardo Guzmán-Ávila, Virginia Flores-Morales |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Results in Chemistry |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211715625004643 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel coumarin chalcone derivatives: synthesis, docking, and antimicrobial evaluation
by: Sumita Kumari, et al.
Published: (2025-02-01) -
In silico design of novel pyridazine derivatives as balanced multifunctional agents against Alzheimer’s disease
by: Mourad Aloui, et al.
Published: (2025-05-01) -
Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel Coumarin–Triazole–Isatin Hybrids as Selective Butyrylcholinesterase Inhibitors
by: Aleksandar Dimkovski, et al.
Published: (2025-05-01) -
Design and synthesis of novel pyridopyrimidine moieties linked to coumarin ring of potentially active cytotoxic agents and their docking study
by: Nehal A. E. Youssef, et al.
Published: (2025-06-01) -
Investigation of Antimicrobial and Anti-Inflammatory Efficacy of Newly Synthesized Pyrogallol-Coumarin Hybrids: <i>In Vitro</i> and <i>In Silico</i> Studies
by: Dušica Simijonović, et al.
Published: (2024-11-01)